🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 604749101 (prev. 60470J103 )
- Market Cap
- Small Cap
- IPO
- 9/30/2015 · $7.00/share
Business: Mirna Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a broad pipeline of microRNA-based oncology therapeutics and is the first to establish clinical proof-of-concept for a microRNA replacement therapy for cancer.
Company Contact
- CEO
- Chris Peetz
- CFO
- Eric Bjerkholt
- Headquarters
- 989 East Hillsdale Boulevard, Suite 300 Foster City, CA 94404
- Phone
- 650-667-4085
- Fax
- 512-681-5201
- Investor Relations
- Andrew McKibben · 650-667-4085 · ir@mirumpharma.com